Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

What is Trulicity used for?

Trulicity (dulaglutide) is a glucagon-like peptide receptor agonist indicated to improve glycemic control and reduce the risk of major adverse cardiovascular events.

Detailed Information

Dulaglutide is a GLP-1 RA indicated

  • as an adjunct to diet and exercise to improve glycemic control in adults with T2DM, and

  • to reduce the risk of MACE in adults with T2DM who have established CV disease or multiple CV risk factors.1

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly


1. Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.


CV = cardiovascular

GLP-1 RA = glucagon-like peptide-1 receptor agonist

MACE = major adverse cardiovascular event

T2DM = type 2 diabetes mellitus

Date of Last Review: July 07, 2020

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical